{
  "retracted": false,
  "timestamp": 1567296000000,
  "updates": [
    {
      "timestamp": 1585240143811,
      "identifier": {
        "doi": "10.1016/j.ejca.2019.04.012"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.ejca.2018.11.031"
  },
  "publisher": "Elsevier BV",
  "title": "Erratum to ‘Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma’ [Eur J Cancer 108 (February 2019) 33–40]"
}
